Expression and clinical significance of galectin-3 in osteosarcoma

Gene

Volumn 546, Issue 2, 2014, Pages 403-407

  Zhou, Xuesong ^a,b   Jing, Jie ^a,b   Peng, Jing ^c   Mao, Wen ^a   Zheng, Yizhou ^a   Wang, Du ^a   Wang, Xin ^a   Liu, Zhiming ^a   Zhang, Xiangming ^a  

^a TONGREN HOSPITAL OF WUHAN UNIVERSITY   (China)

^b WUHAN UNIVERSITY   (China)

^c Department of Orthopaedics Wuhan Traditional Chinese Medicine University   (China)

Author keywords

Expression; Galectin 3; Immunohistochemistry; Osteosarcoma; Serum

Indexed keywords

GALECTIN 3;

ADOLESCENT; ADULT; ARTICLE; CANCER STAGING; CANCER TISSUE; CHILD; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; OSTEOSARCOMA; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; BLOOD LEVEL; CANCER PATIENT; CLINICAL ARTICLE; HISTOPATHOLOGY; METASTASIS;

EXPRESSION; GALECTIN-3; IMMUNOHISTOCHEMISTRY; OSTEOSARCOMA; SERUM;

ADOLESCENT; ADULT; BONE NEOPLASMS; CHILD; FEMALE; GALECTIN 3; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; NEOPLASM METASTASIS; NEOPLASM PROTEINS; NEOPLASM STAGING; OSTEOSARCOMA; PROGNOSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 84903519800     PISSN: 03781119     EISSN: 18790038     Source Type: Journal    
DOI: 10.1016/j.gene.2014.04.066     Document Type: Article

References (27)

1. Aljubran A.H., Griffin A., Pintilie M., Blackstein M. Osteosarcoma in adolescents and adults: survival analysis with and without lung metastases. Annals of Oncology 2009, 20(6):1136-1141.
2. Camby I., Belot N., Rorive S., Lefranc F., Maurage C.A., Lahm H., Kaltner H., Hadari Y., Ruchoux M.M., Brotchi J., Zick Y., Salmon I., Gabius H.J., Kiss R. Galectins are differentially expressed in supratentorial pilocytic astrocytomas, astrocytomas, anaplastic astrocytomas and glioblastomas, and significantly modulate tumor astrocyte migration. Brain Pathology 2001, 11(1):12-26.
3. Castronovo V., van den BrÛle F.A., Jackers P., Clausse N., Liu F.T., Gillet C., Sobel M.E. Decreased expression of galectin-3 is associated with progression of human breast cancer. The Journal of Pathology 1996, 179:43-48.
4. Cheng C.S., Dong W.G., Luo H.S., Yu B.P. Expression of galectin-3 in gastric carcinoma and its significance. Chinese Journal of Cancer Research 2004, 16(3):176-181.
5. Dumic J., Dabelic S., Flogel M. Galectin-3: an open-ended story. Biochimica et Biophysica Acta 2006, 1760:616-635.
6. Endo K., Kohnoe S., Tsujita E., Watanabe A., Nakashima H., Baba H., Maehara Y. Galectin-3 expression is a potent prognostic marker in colorectal cancer. Anticancer Research 2005, 25:3117-3122.
7. Gao P., Simpson J.L., Zhang J., Gibson P.G. Galectin-3: its role in asthma and potential as an anti-inflammatory target. Respiratory Research 2013, 14:136.
8. Gorlick R., Anderson P., Andrulis I. Biology of childhood osteogenic sarcoma and potential targets for therapeutic development: meeting summary. Clinical Cancer Research 2003, 9:5442-5453.
9. Honjo Y., Nangia-Makker P., Inohara H., Raz A. Down-regulation of galectin-3 suppresses tumorigenicity of human breast carcinoma cells. Clinical Cancer Research 2001, 7(3):661-668.
10. Hoyer K.K., Pang M., Gui D., Shintaku I.P., Kuwabara I., Liu F.T., Said J.W., Baum L.G., Teitell M.A. An anti-apoptotic role for galectin-3 in diffuse large B-cell lymphomas. The American Journal of Pathology 2004, 164(3):893-902.
11. Inohara H., Honjo Y., Yoshii T., Akahani S., Yoshida J., Hattori K., Okamoto S., Sawada T., Raz A., Kubo T. Expression of galectin-3 in fine-needle aspirates as a diagnostic marker differentiating benign from malignant thyroid neoplasms. Cancer 1999, 85:2475-2484.
12. Joo H.G., Goedegebuure P.S., Sadanaga N., Nagoshi M., von Bernstorff W., Eberlein T.J. Expression and function of galectin-3, a β-galactoside-binding protein in activated T lymphocytes. Journal of Leukocyte Biology 2001, 69:555-564.
13. Lee J.W., Song S.Y., Choi J.J., Choi C.H., Kim J., Lee J.H., Kim B.G., Bae D.S. Decreased galectin-3 expression during the progression of cervical neoplasia. Journal of Cancer Research and Clinical Oncology 2006, 132:241-247.
14. Miyazaki J., Hokari R., Kato S., Tsuzuki Y., Kawaguchi A., Nagao S., Itoh K., Miura S. Increased expression of galectin-3 in primary gastric cancer and the metastatic lymph nodes. Oncology Reports 2002, 9(6):1307-1312.
15. Nangia-Makker P., Honjo Y., Sarvis R., Akahani S., Hogan V., Pienta K.J., Raz A. Galectin-3 induces endothelial cell morphogenesis and angiogenesis. The American Journal of Pathology 2000, 156(3):899-909.
16. Nangia-Makker P., Balan V., Raz A. Regulation of tumor progression by extracellular galectin-3. Cancer Microenvironment 2008, 1(1):43-51.
17. Pacis R.A., Pilat M.J., Pienta K.J., Wojno K., Raz A., Hogan V., Cooper C.R. Decreased galectin-3 expression in prostate cancer. The Prostate 2000, 44:118-123.
18. Portt L., Norman G., Clapp C., Greenwood M., Greenwood M.T. Anti-apoptosis and cell survival: a review. Biochimica et Biophysica Acta 2011, 1813(1):238-259.
19. Raimond J., Zimonjic D.B., Mignon C., Mattei M., Popescu N.C., Monsigny M., Legrand A. Mapping of the galectin-3 gene (LGALS3) to human chromosome 14 at region 14q21-22. Mammalian Genome 1997, 8(9):706-707.
20. Shimura T., Takenaka Y., Tsutsumi S., Hogan V., Kikuchi A., Raz A. Galectin-3, a novel binding partner of β-catenin. Cancer Research 2004, 64:6363-6367.
21. Ta H.T., Dass C.R., Choong P.F., Dunstan D.E. Osteosarcoma treatment: state of the art. Cancer Metastasis Reviews 2009, 28:247-263.
22. Takenaka Y., Knohara H., Yoshii T., Oshima K., Nakahara A., Akahani S., Honjo Y., Yamamoto Y., Raz A., Kubo Y. Malignant transformation of thyroid follicular cells by galectin-3. Cancer Letters 2003, 195:1-9.
23. Tromp S.C., oude Egbrink M.G., Dings R.P., van Velzen S., Slaaf D.W., Hillen H.F., Tangelder G.J., Reneman R.S., Griffioen A.W. Tumor angiogenesis factors reduce leukocyte adhesion in vivo. International Immunology 2000, 12(5):671-676.
24. van den BrÛle F.A., Buicu C., Sobel M.E., Liu F.T., Castronovo V. Galectin-3, a laminin binding protein, fails to modulate adhesion of human melanoma cells to laminin. Neoplasma 1995, 42:215-219.
25. Yang R.Y., Hsu D.K., Liu F.T. Expression of galectin-3 modulates T-cell growth and apoptosis. Proceedings of the National Academy of Sciences of the United States of America 1996, 93:6737-6742.
26. Zhou X.S., Zhang R.L. Fascin gene expression in osteosarcoma and statistical analysis. Journal of Mathematical Medicine 2010, 23(5):558-560. (in Chinese).
27. Zhou Y.Q., Zhou X.K., Kong Y.Y., Song C.Y., Wu X.H. Expression of galectin-3 in cervical cancer and its clinical significance. Tumor 2011, 31(2):148-153. (in Chinese).